Everence Capital Management Inc. Sells 1,160 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Everence Capital Management Inc. reduced its position in Mettler-Toledo International Inc. (NYSE:MTD) by 67.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 550 shares of the medical instruments supplier’s stock after selling 1,160 shares during the period. Everence Capital Management Inc.’s holdings in Mettler-Toledo International were worth $673,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. State Street Corp lifted its stake in shares of Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after buying an additional 9,009 shares in the last quarter. Geode Capital Management LLC lifted its position in Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after acquiring an additional 4,166 shares in the last quarter. Barclays PLC lifted its position in Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after acquiring an additional 19,609 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Finally, Loomis Sayles & Co. L P increased its holdings in Mettler-Toledo International by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after purchasing an additional 3,644 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Up 1.4 %

NYSE:MTD opened at $1,238.28 on Friday. Mettler-Toledo International Inc. has a 12 month low of $1,115.64 and a 12 month high of $1,546.93. The firm’s 50 day moving average is $1,256.98 and its 200 day moving average is $1,356.20. The stock has a market capitalization of $26.13 billion, a PE ratio of 33.39, a price-to-earnings-growth ratio of 4.21 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on MTD. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their target price for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating on the stock. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $1,375.00 to $1,450.00 in a report on Thursday. Finally, Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.